Case	case	O	O	O	O
report	report	O	O	O	O
:	:	O	O	O	O
pentamidine	pentamidine	O	O	OTHERS	I
and	and	O	O	O	O
polymorphic	polymorphic	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
tachycardia	tachycardia	O	DISEASE	OTHERS	I
revisited	revisited	O	O	O	O
.	.	O	O	O	O

Pentamidine	pentamidine	O	O	OTHERS	I
isethionate	isethionate	O	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
ventricular	ventricular	O	O	OTHERS	I
tachyarrhythmias	tachyarrhythmias	O	O	OTHERS	I
,	,	O	O	O	O
including	including	O	O	O	O
torsade	torsade	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
article	article	O	O	O	O
reports	reports	O	O	O	O
two	two	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
complication	complication	O	O	O	O
and	and	O	O	O	O
reviews	reviews	O	O	O	O
all	all	O	O	O	O
reported	reported	O	O	O	O
cases	cases	O	O	O	O
to	to	O	O	O	O
date	date	O	O	O	O
.	.	O	O	O	O

Pentamidine-induced	pentamidine-induced	O	O	O	O
torsade	torsade	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
serum	serum	O	O	O	O
magnesium	magnesium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
and	and	O	O	O	O
hypomagnesemia	hypomagnesemia	O	O	OTHERS	I
may	may	O	O	O	O
synergistically	synergistically	O	O	O	O
induce	induce	O	O	O	O
torsade	torsade	O	O	O	O
.	.	O	O	O	O

Torsade	torsade	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
after	after	O	O	O	O
an	an	O	O	O	O
average	average	O	O	O	O
of	of	O	O	O	O
10	10	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
pentamidine	pentamidine	O	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
no	no	O	O	O	O
other	other	O	O	O	O
acute	acute	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
pentamidine	pentamidine	O	O	OTHERS	I
were	were	O	O	O	O
observed	observed	O	O	O	O
.	.	O	O	O	O

Torsade	torsade	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
can	can	O	O	O	O
be	be	O	O	O	O
treated	treated	O	O	O	O
when	when	O	O	O	O
recognized	recognized	O	O	O	O
early	early	O	O	O	O
,	,	O	O	O	O
possibly	possibly	O	O	O	O
without	without	O	O	O	O
discontinuation	discontinuation	O	O	O	O
of	of	O	O	O	O
pentamidine	pentamidine	O	O	OTHERS	I
.	.	O	O	O	O

When	when	O	O	O	O
QTc	qtc	O	O	OTHERS	I
interval	interval	O	O	OTHERS	I
prolongation	prolongation	O	O	OTHERS	I
is	is	O	O	O	O
observed	observed	O	O	O	O
,	,	O	O	O	O
early	early	O	O	O	O
magnesium	magnesium	CHEMICALS	O	OTHERS	I
supplementation	supplementation	O	O	O	O
is	is	O	O	O	O
advocated	advocated	O	O	O	O
.	.	O	O	O	O

